CARD6: A Potential Drug Target and Biomarker (G84674)

Target Name: CARD6

NCBI ID: G84674

CARD6

CARD6: A Potential Drug Target and Biomarker

Caspase recruitment domain family member 6 (CARD6) is a protein that plays a critical role in cell signaling pathways. It is a member of the Caspase- recruitment domain family, which is a family of proteins that are involved in the recruitment of caspases to their respective cation channels. CARD6 is a 21-kDa protein that is expressed in various tissues and cells, including muscle, heart, and brain.

The function of CARD6 is to recruit caspases to their cation channels, which are critical for the regulation of intracellular signaling pathways. Caspases are proteins that play a central role in cell signaling pathways, as they regulate the progress of various cellular processes, including cell death , apoptosis, and inflammation. The recruitment of caspases to their cation channels is a critical step in these processes, as it allows the caspases to perform their functions efficiently.

CARD6 is involved in various cellular processes, including cell signaling, cell adhesion, and neurotransmission. It is a key regulator of the neurotransmitter receptor tyrosine kinase (EGFR), which is involved in cell signaling pathways, including cell growth, survival, and angiogenesis. CARD6 has also been shown to be involved in the regulation of neurotransmitter release from neuro axons, which is critical for the transmission of signals in the nervous system.

CARD6 has also been shown to be involved in the regulation of cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. CARD6 is a key regulator of cell-cell adhesion, as it is involved in the formation of tight junctions and adherens junctions, which are critical for the formation of tissues.

In addition to its role in cell signaling and adhesion, CARD6 is also involved in the regulation of neurotransmission. Neurotransmission is the process by which neurons transmit signals between neurons, and it is critical for the function of the nervous system. CARD6 is involved in the regulation of neurotransmission, as it is involved in the release of neurotransmitters from neuronal axons.

CARD6 is a potential drug target, as it is involved in various cellular processes that are important for the function of the nervous system. It is possible that blocking the activity of CARD6 could be a useful way to treat various neurological and psychiatric disorders. For example , CARD6 has been shown to be involved in the regulation of neurotransmission in the treatment of Alzheimer's disease.

In addition to its potential as a drug target, CARD6 is also a potential biomarker for various neurological and psychiatric disorders. The regulation of CARD6 activity has been implicated in the development and progression of various neurological and psychiatric disorders, including Alzheimer's disease.

In conclusion, CARD6 is a protein that plays a critical role in cell signaling pathways and various cellular processes, including cell adhesion and neurotransmission. It is a potential drug target and biomarker for various neurological and psychiatric disorders. Further research is needed to fully understand the function of CARD6 and its potential as a drug and biomarker.

Protein Name: Caspase Recruitment Domain Family Member 6

Functions: May be involved in apoptosis

The "CARD6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CARD6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets